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Alterations in reward processes may underlie motivational and anhedonic symptoms in depression and schizophrenia. However it remains
unclear whether these alterations are disorder-specific or shared, and whether they clearly relate to symptom generation or not. We
studied brain responses to unexpected rewards during a simulated slot-machine game in 24 patients with depression, 21 patients with
schizophrenia, and 21 healthy controls using functional magnetic resonance imaging. We investigated relationships between brain
activation, task-related motivation, and questionnaire rated anhedonia. There was reduced activation in the orbitofrontal cortex, ventral
striatum, inferior temporal gyrus, and occipital cortex in both depression and schizophrenia in comparison with healthy participants during
receipt of unexpected reward. In the medial prefrontal cortex both patient groups showed reduced activation, with activation significantly
more abnormal in schizophrenia than depression. Anterior cingulate and medial frontal cortical activation predicted task-related motivation,
which in turn predicted anhedonia severity in schizophrenia. Our findings provide evidence for overlapping hypofunction in ventral striatal
and orbitofrontal regions in depression and schizophrenia during unexpected reward receipt, and for a relationship between unexpected
reward processing in the medial prefrontal cortex and the generation of motivational states.
Neuropsychopharmacology advance online publication, 20 January 2016; doi:10.1038/npp.2015.370
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INTRODUCTION
Depression and schizophrenia are associated with deficits in
motivation and enjoyment, which have been collectively
termed anhedonia by some authors (James, 1902). Clinically
it is challenging to distinguish between deficits in pleasure
and motivation, even though there are at least partially
separable processes that underpin these functions (Berridge
and Robinson, 2003). Some evidence suggests that striatal
hypofunction during reward processing is present in
schizophrenia and depression, and may contribute to the
motivational and hedonic problems experienced by patients
(Juckel et al, 2006; Smoski et al, 2009), whilst other
authors have emphasized the importance of orbitofrontal
cortex function in this regard (Morris et al, 2011; Gold et al,
2012). It remains unknown whether the neurobiological
disturbances in reward processing are different in schizo-
phrenia and depression and it is not yet clear which aspects
of reward processing are particularly problematic in these
conditions, or whether any associated neural deficits are
predominantly cortical or subcortical in origin. Insights into
any shared pathophysiology underlying abnormalities in
motivation and pleasure across different psychiatric
diagnoses could lead to improved use of existing treatments,
facilitate development of new treatments and, as is postulated
by the Research Domain Criteria (RDoC) project, may
contribute to improved psychiatric classification in the future
(Heinz et al, 1994; Insel et al, 2010; Hägele et al, 2014).
Recently it has been suggested that in both schizophrenia
and depression, the aspects of reward processing that relate
to reward receipt may be relatively spared, whereas
anticipatory and motivational aspects of reward processing
may be more dysfunctional and may be closely linked to
negative symptoms/depression (Argyropoulos and Nutt,
2013; Dillon et al, 2014; Kring and Caponigro, 2010; Barch
and Dowd, 2010). However, the majority of neuroimaging
studies that have examined reward receipt in schizophrenia
and depression have used tasks where rewards are rather
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predictable, and can be expected to occur more often than
not; several studies using such tasks have found broadly
intact neural responses to reward feedback in schizophrenia
and depression (eg, Abler et al, 2008; Simon et al, 2010;
Smoski et al, 2011; Dowd and Barch, 2012; Gilleen et al,
2015). Such tasks are optimized to examine brain responses
during the anticipation and receipt of a highly expected
reward, rather than unexpected reward responses; several
studies have documented robust striatal and cortical
deficits in schizophrenia and depression in the anticipation
of reward.
This still leaves open the question as to whether response
to reward receipt, especially unexpected reward receipt, is
normal in these disorders (Barch and Dowd, 2010; Strauss
et al, 2014). In this regard it is critical to examine neural
responses to unpredicted rewards, which may be more
pronounced than those to predicted rewards (Schultz et al,
1997). This is of particular interest, given that unexpected
events evoke prediction errors, which are encoded within the
brain at both cortical and subcortical levels (Schultz and
Dickinson, 2000; Garrison et al, 2013). Prediction error
signaling has been postulated to relate to many aspects of
thought and behavior in health and in psychiatric illness,
including learning, motivation, and attention, and abnormal
brain prediction error signaling may contribute to psychotic
symptoms as well as deficits in motivation and enjoyment
(Fletcher and Frith, 2009; Murray, 2009; Ziauddeen and
Murray, 2010; Gradin et al, 2011).
Initial evidence suggests that the prediction error signaling
during, or after, learning may be compromised in both
schizophrenia and depression in cortical and subcortical
regions (Murray et al, 2008; Kumar et al, 2008; Waltz et al,
2009; Gradin et al, 2011; although see Dowd and Barch,
2012). However, abnormal neural correlates of prediction
error associated learning signals may reflect dysfunction of
the learning mechanism (eg, failure to update in response to
prediction error signals during learning), not necessarily to
the prediction error signaling mechanism per se. To fully
assess the integrity of neural systems that signal surprising/
unexpected rewards, it is critical to employ an experimental
scenario with little or no learning component in which
reward outcome is unpredictable (Morris et al, 2012).
Our aim therefore was to explore brain responses to
unexpected reward delivery in both depression and
schizophrenia, and their relationship to motivation and
enjoyment. We used an fMRI reward processing task
involving the receipt of unexpected rewards, but minimal
learning, with a sample of patients who all subjectively
endorsed at least some degree of anhedonia. Our goals were:
1. to test whether brain responses to unexpected rewards
were broadly intact in schizophrenia and depression,
2. if brain responses to unexpected rewards are abnormal in
schizophrenia and depression, to evaluate if the deficits
are confined to cortical, or subcortical regions, and
whether there are any shared or differential areas of
deficit in the two disorders, and
3. to examine whether brain responses to unexpected reward
receipt are related to motivation and enjoyment in these
disorders.
MATERIALS AND METHODS
Participants
The study was approved by the Cambridgeshire 3 National
Health Service research ethics committee. Written informed
consent was obtained from all participants.
Twenty-one people with DSM-IV schizophrenia, 24 people
with DSM-IV major depressive disorder (MDD), and 21
healthy volunteers took part in the study (Table 1).
All schizophrenia participants were taking antipsychotic
medication; eight were additionally taking antidepressant
medication. Thirteen of the 24 depression participants were
taking antidepressant medication, of whom four were
additionally taking antipsychotic medication; medication is
described in Table 1 and in further detail in Supplementary
Material. Inclusion criteria were an age between 18 and 65
and adequate proficiency in English. Exclusion criteria were
history of neurological disorder, physical illness, dependence
Table 1 Subjects’ Demographics and Clinical Characteristics
Controls (n= 21)
mean/SD
Depression (n= 24)
mean/SD
Schizophrenia (n= 21)
mean/SD
F/X2 P-value Post hoc tests
Age 34.33/± 10.11 33.08± 9.15 32.24± 7.44 0.29 0.749
Gender (male/female) 17/4 17/7 18/3 1.712 0.425
Handedness (right/left) 18/3 22/2 16/5 2.004 0.367
White-British 17 20 17 0.044 0.978
Culture fair (IQ) 114.24± 19.97 107.08± 16.6 100.20± 19.28 2.93 0.061
Education (years) 14.85± 1.93 13.43± 2.21 13.50± 2.09 3.01 0.057
BPRS 43.14± 11.89
BDI total 4.29± 4.89 32.62± 7.06 21.05± 8.95 88.19 o0.001 CoD CoS SoD
SHAPS 23.38± 3.58 33.42± 6.81 29.19± 6.2 17.00 o0.001 CoD CoS SoD
Antipsychotics (chlorpromazine equivalents) a 377± 424
Antidepressants prescribed 13 (54%) 8 (38%)
aFour depression participants were prescribed low-dose antipsychotic medication; see Supplementary Text for further medication details. Any significant post hoc test
results for two-group comparisons (po0.05) are also indicated by the use of ‘greater than’ symbols.
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on alcohol or recreational drugs, and any contraindication
for MRI scanning. A first-degree family history of schizo-
phrenia or bipolar disorder was an additional exclusion
criterion in the depression and control groups. All partici-
pants with depression or schizophrenia subjectively endorsed
a degree of loss of interest or pleasure.
Anhedonia Assessment
To assess anhedonia we used the Snaith Hamilton Pleasure
Scale (SHAPS), a validated self-report measure (Snaith et al,
1995; Franken et al, 2007).
fMRI Task Description
The task involved playing a computerized version of a
slot-machine game; participants view two reels of a
slot-machine/one arm bandit game, where the left hand reel
is stationary and the right hand reel spins until it stops
(Figure 1). If the two icons in the center of view match, there
is a financial reward of 50 pence. Participants win on an
average one in six trials, making rewards unexpected in this
game. Furthermore, the duration of the spinning of the wheel
is variable in this task (delay varies between 2.8 and 6 s),
so the precise timing of the outcome is also not predictable.
The game consisted of two runs of 60 trials, each run lasting
~ 20 min, and has been previously described (Clark et al,
2009). On 50% of trials, the participant selects the ‘play
icon’—the image in the center of the left hand reel—by
rotating the reel to the icon of their choice. In the other 50%
of trials (pseudorandomised distribution), the computer
selects the ‘play icon’; on these trials the participant is
required to confirm with a button press that he/she has noted
the computer choice. After this selection phase the right
hand reel starts to spin. The selection phase lasts 5 s, followed
by a variable delay stage whilst the second reel spins and
comes to a stop, followed by an outcome phase of 4 s where
the reward is presented: ‘£0.50 win!’ (if the icons on the
payline of the two reels match) or ‘No win’ (if they do not
match). If selection/confirmation did not occur within 5 s,
‘too late’ was presented on the screen and the task moved on
to the next trial. At the end of each trial, there was a variable
inter-trial interval of between 2 and 7 s duration. Participants
were told that they would be given any money they won at
the end of the experiment.
Task-related pleasure and motivation. Immediately after
the scan session the participants answered the questions,
‘When the second picture matched the chosen picture you
won money. How much did you like the feeling of winning
money?’ and, ‘When the second picture matched the chosen
picture you won money. Did this make you want to play
more?’ The answers were marked on a visual analog scale.
fMRI Data Acquisition and Pre-Processing
A Siemens Trio Tim operating at 3T was used to collect
imaging data. Gradient-echo T2*-weighted echo planar
images depicting BOLD contrast were acquired from 32
noncontiguous oblique axial planes to minimize signal
drop-out in ventral regions. TR= 2 s; echo time= 30 ms;
flip angle= 78; voxel size= 3.14 × 3.14 × 3.75 mm3, matrix
size 64 × 64; bandwidth 2232 HZ/Px. A high-resolution
T1-weighted three-dimensional MP-RAGE structural
image was also acquired for use in spatial normalization
of the EPI series. Imaging data was analyzed using
FSL software (FMRIB’s Software Library, www.fmrib.ox.ac.
uk/fsl). See Supplementary Material for pre-processing
details.
fMRI Data Analysis
An event-related analysis in FSL software was used to identify
neural responses at the time of the unexpected win. We used a
single statistical linear regression model with four explanatory
variables and their temporal derivatives: (a) anticipation phase
(the duration of this event varied between 2.8 and 6 s on
different trials); (b) win outcome (4 s duration, 20 events in
total); (c) near-miss outcomes (4 s duration, 40 events in
total); (d) full-miss outcomes (4 s duration, 60 events in total).
A near-miss outcome is where the play icon finishes adjacent
to, but not on, the payline; near-miss outcomes have been
shown to evoke neural responses different to other misses
(Clark et al, 2009). Movement parameters from the realign-
ment step were also included in the first-level model.
As our hypotheses concerned brain activation in response
to unexpected reward, an ‘unexpected reward receipt’
contrast was investigated, formed by the contrast of win
outcomes vs full-miss outcomes. This contrast was computed
at the single-participant level and the β-parameters for
participants from this contrast were carried forward to group
analyses. One-way between participants ANOVA was
conducted at the whole-brain level to compare between the
three groups. The one-way ANOVA only identifies regions
in which activation is different between groups, without
indicating which groups drive the differences or the
directionality of the differences. Therefore, for clusters in
which the ANOVA indicated group differences we extracted
the mean parameter estimates for each subject for that
cluster (using the FSL tool Featquery) and conducted
post hoc comparisons across groups. Regression analyses at
the whole-brain level in FSL were used to investigate
relationships between brain activation and the post-scan
subjective ratings of motivation and pleasure.
Figure 1 Example of a ‘win trial’ in the fMRI simulated slot-machine game.
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Imaging comparisons were cluster thresholded using the
FSL tool easythresh, using a family-wise error (FWE)
correction at po0.05 (initial cluster threshold z= 2).
RESULTS
Demographics and Rating Scales
Groups did not differ in age, gender, handedness, years of
education, IQ, or ethnicity (Table 1).
Patients with depression had higher SHAPS anhedonia
scores than healthy controls and patients with schizophrenia.
Patients with schizophrenia had higher SHAPS anhedonia
scores compared with controls (Table 1).
The three groups did not differ on a visual analog measure
of how much they valued 50 pence (answer to question ‘how
often do you pick up a 50 pence coin when you see it in the
street’; p= 0.843).
Behavioral Analysis
Reward task wins. There were no differences in the
number of wins according to group, reflecting the pseudo-
randomized nature of the paradigm (wins F= 2.23, df= 2,65,
p= 0.11).
Reward task post-scan questions (reward liking and task
motivation). Participants with depression reported signifi-
cantly lower liking of the feeling of winning money than
controls (depression: mean= 56.3, SD= 23.2; controls:
mean= 74.3, SD= 21.0; t= 2.7, df= 43, p= 0.009). In this
measure of liking there was a marginal difference between
schizophrenia participants (mean= 61.1, SD= 27.9) and con-
trols (t= 1.75, df= 40, p= 0.09), and no difference between
schizophrenia and depression participants (t= 0.65, df= 43,
p= 0.52).
In response to the question ‘When the second picture
matched the chosen picture you won money. Did this make
you want to play more?’, there was a significantly higher
score in controls (mean= 67.0, SD= 29.2) than depression
patients (mean= 44.4, SD= 25.7; comparison t= 2.87,
df= 42, p= 0.009). Controls scored higher than schizophre-
nia patients on this measure with marginal statistical
significance (schizophrenia: mean= 48.3, SD= 30.4; compar-
ison controls vs schizophrenia t= 2.0, df= 39, p= 0.05).
There was no significant difference between depression and
schizophrenia on this motivational measure (t= 0.66, df= 43,
p= 0.64). One control had missing data on this measure.
Associations with anhedonia questionnaire. Higher
SHAPS anhedonia scores were associated with lower
reported motivation ratings in the whole sample (β=− 0.3,
t= 2.6, p= 0.01), and in the schizophrenia group (β=− 0.7,
t= 4.3, po0.001). SHAPS anhedonia also negatively pre-
dicted the pleasure ratings after a win in the whole sample
(β=− 0.3, t=− 2.2, p= 0.03).
Brain Imaging Results
We evaluated activation associated with unexpected reward
receipt using the contrast of a win outcome vs full-loss
outcome.
Entire sample (one sample t-test). There was a
highly significant brain response in a widespread cortico-
striatal network including the striatum, orbitofrontal
cortex and medial prefrontal cortex. The maximum
significance was located in left caudate (MNI x=− 8,
y= 10, z= 2; Z-score= 9.28; Figure 2, Supplementary
Figures S1 and S4).
Between group analysis. One-way ANOVA analysis de-
monstrated 10 clusters with significant group differences
(Figure 2, Table 2, Supplementary Figures S2). Post hoc
pairwise tests of mean cluster parameter estimates showed
that, in comparison to healthy controls, MDD and schizo-
phrenia participants had a decreased signal (eg, Figure 3
upper panel) to unexpected rewards in clusters that
encompassed bilateral orbitofrontal cortex, right caudate,
right nucleus accumbens, right midbrain, right thalamus,
right inferior and middle temporal gyrus, and left
occipital cortex.
The post hoc tests also revealed that in the medial
prefrontal cortex, in a cluster including the paracingulate
gyrus and superior frontal gyrus, both patient groups had
reduced activity compared with controls, and the schizo-
phrenia group also had significantly lower activation
compared with depression.
Compared with controls, the schizophrenia group had
significantly lower activations in the posterior division of the
cingulate gyrus, right occipital pole, and bilateral
cerebellar areas.
The posterior lateral parietal cortex bilaterally (angular
and supramarginal gyri, and intraparietal sulci)
showed reduced activation in schizophrenia (compared
with depression and controls) but there were no differences
here between depression and controls (Figure 3, lower
panel).
Our results are based on the contrast of unexpected
reward receipt vs full miss. Examination of the parameter
estimates for the regressors that make up this
contrast (ie, their activation compared with baseline) suggest
that the group differences were secondary to reduced
patient responses to unexpected reward receipt rather
than differences in full-miss activation (Supplementary
Figure S25).
Associations with subjective experience. In a regression
analysis in which we pooled all participants and,
importantly, adjusted for group effects by modeling group
means, brain activation during receipt of unexpected reward
was positively associated (po0.05 corrected) with the post-
scan rating of motivation to keep playing the task after a win
in a medial prefrontal cluster situated in the anterior
cingulate and paracingulate gyrus and bilateral medial
superior frontal gyrus (cluster size= 2491, z maximum peak
voxel= 4.17, MNI coordinates x=− 12, y= 52, z= 24;
Figure 4; Supplementary Figure S3). The strength of this
association did not differ between groups (group X
motivation interaction term p= 0.9). Activation in this
region was not significantly associated with SHAPS total
score. No associations were found between unexpected
reward receipt and the hedonic feeling of winning money
at po0.05 corrected.
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Relationship to Medication
There were no differences in activation when comparing
those depression participants with and without antidepres-
sant treatment. Within the schizophrenia group, we
converted treatment doses into chlorpromazine equivalents
and found no associations with brain response. See
Supplementary Material for more detail.
DISCUSSION
We used fMRI to examine brain activation to unexpected
reward (positive reward prediction error) without learning
confounds. The task we used, which had not been employed
before in samples with mental illness, elicited activation to
unexpected reward receipt in the classic reward network
including striatum, orbitofrontal cortex, and medial
prefrontal cortex, and yielded insights into relationships
between brain activation and subjective experience during
the experiment. We demonstrated that brain responses to
unexpected rewards are suppressed in a similar way in both
schizophrenia and depression in several regions previously
implicated in the pathology of both of these disorders,
including the orbitofrontal cortex, ventral striatum,
thalamus, and insular cortex. However, there were also areas
of deficit unique to schizophrenia, such as the posterior
lateral parietal cortex. When we examined relationships
between brain activation and task-related emotional reports,
we found intriguing associations between medial prefrontal
unexpected reward receipt responses and motivational state
that could help explain aspects of clinical anhedonia.
Group Differences
Our results indicated reduced activation to the receipt of an
unexpected reward in overlapping regions in schizophrenia
and depression: the orbitofrontal cortex, ventral striatum,
thalamus, and inferior and middle temporal gyri had reduced
activation in both disorders. There is a previous report
of reduced ventral striatal reward receipt responses in
unmedicated depression participants (Robinson et al,
2012); in schizophrenia participants lower striatal activity
has been described in response to an uncertain primary
reward (Waltz et al, 2009) and to an unexpected monetary
reward (Morris et al, 2012). However, some previous studies
have documented that processing of unexpected rewards is
Figure 2 fMRI results: receipt of unexpected reward. Left hemisphere is shown in the right side of the image. Coordinates are expressed in mm, and in
standard space. Panel a: entire sample pooled analysis. The yellow color indicates significant voxels thresholded at po0.05 family-wise error (FWE) voxelwise
corrected for illustrative purposes. Panel b: between groups analysis using ANOVA. Colored clusters indicate those clusters indicating significant group
differences (cluster threshold Z42.0 po0.05 FWE whole-brain cluster corrected) and the particular color indicates the results of post hoc tests. Green areas
are clusters where the control group has greater activation compared with the depression group and compared with the schizophrenia group; blue areas are
clusters where controls have greater activation compared with the depression group and compared with the schizophrenia group, and the depression group
has greater activation than the schizophrenia group; red areas are clusters where controls have more activation than the schizophrenia group and the
depression group has more activation than the schizophrenia group; lilac areas are clusters those where the control group has more activation than the
schizophrenia group.
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intact in schizophrenia, and in some circumstances it is not
possible to detect case-control differences in psychological
and/or brain responses to rewards (Gard et al, 2007; Dowd
and Barch, 2012). A variety of methodological factors will
influence the likelihood of individual studies showing
significant groups differences, including sample size, the
present symptoms of the patients, the sensitivity of the
particular paradigm involved, and whether a motor response
is required or not. In the paradigm used in the present study
rewards were not predictable, as they occurred at variable
times (between 2.8 and 6 s after the reel started to spin) and
were uncommon (occurring in one sixth of trials in a
pseudo-randomized pattern), and as such these rewards are
associated with positive prediction error.
Because not all patients with schizophrenia or depression
have difficulties in motivation and enjoyment, patient
heterogeneity may also contribute to variability of the results
in the existing literature. Our results, in a study where all
patients had at least some degree of anhedonia, indicate
that striatal, insular, thalamic, temporal cortex, and orbito-
frontal cortex processing of unexpected rewards may be
abnormal in both schizophrenia and depression, which may
impact on hedonic experience, the ability to learn reward-cue
relationships and the generation of motivational states.
One previous study compared reward prediction error
responses in participants with depression, participants with
schizophrenia and controls (Gradin et al, 2011); that study
scanned participants during learning, and the current study
extends these results to demonstrate, in a task where no
learning is required, areas of overlapping and differential
response associated with reward prediction error in schizo-
phrenia and depression. In addition, whilst Gradin et al
(2011) examined brain responses correlating with a compo-
site measure of positive and negative prediction error, our
Figure 3 Left panel: yellow color indicates a significant cluster resulting from the linear regression of brain activation during an unexpected win against
subjective ratings of task-related motivation (all participants pooled, adjusted by group). Left hemisphere is shown in the right side of the image. Coordinates
are expressed in mm, and in standard space. FWE whole-brain corrected, cluster threshold Z42.0 po0.05. Centre panel: scatterplot of the extracted contrast
parameter estimates during an unexpected win from the cluster depicted in left panel vs subjective task-related motivation (blue square, controls; green
triangle, depression; red circle, schizophrenia). Right panel: scatterplot of SHAPS (Snaith Hamilton pleasure scale) score vs the subjective rating of motivation in
the schizophrenia group.
Table 2 Unexpected Reward Receipt Group Differences (One-Way ANOVA Implemented in FSL, FWE Corrected, Cluster Threshold
Z42.0, po0.05.)
Anatomical location Cluster size Z-score MNI coordinates Post hoc test
x y z
Medial frontal cortex (right superior frontal gyrus and paracingulate) 754 3.52 14 30 56 C4S; C4D; D4S
Right ventral striatum orbitofrontal cortex, thalamus, and midbrain 1977 4.25 8 6 − 2 C4D; C4S
Left lingual gyrus, occipital lobe 1577 3.72 − 6 − 80 2 C4D; C4S
Left orbitofrontal cortex 1120 3.4 − 48 40 − 22 C4D; C4S
Right inferior and middle temporal gyri 742 3.52 62 − 26 − 22 C4D; C4S
Right occipital pole and right cerebellum 2631 4.85 − 20 − 100 6 C4S
Posterior cingulate gyrus 830 4.33 0 − 24 30 C4S
Left cerebellum 705 4.23 − 14 − 76 − 34 C4S
Right angular and supramarginal gyri, parietal lobe 1815 4.75 54 − 54 40 C4S; D4S
Left angular and supramarginal gyri, parietal lobe 1016 4.02 − 40 − 62 40 C4S; D4S
Abbreviations: C, controls; D, depression; MNI, Montreal Institute of Neurology; S, schizophrenia.
The Z-score for the maximum peak value of each cluster is provided. Any significant post hoc test results for two-group comparisons (po0.05) on extracted contrast
parameter estimates are also indicated for each cluster by the use of ‘greater than’ symbols.
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study focuses on positive reward prediction error: given that
rewards are infrequent in our task, there are no trials in this
task where strong expectancies of a win are violated.
Although our results indicate many shared areas of reward
processing deficit in schizophrenia and depression, there are
also areas of difference. There were schizophrenia specific
deficits in unexpected reward receipt activation in the
posterior cingulate gyrus, occipital pole, and cerebellum:
these areas were not significantly abnormal in depression,
although post hoc analysis did not demonstrate significant
differences in activation between patient groups. We note
there were however significant differences between
the patient groups in the lateral parietal cortex, in the
supramarginal and angular gyri, and intraparietal sulci,
which had abnormal activation in schizophrenia but not
depression, confirmed in an additional analysis using
exclusive masking (see Supplementary Text and
Supplementary Figures S11 and S12). There is previous
evidence for the role of this part of the parietal cortex in
signaling surprising outcomes (Nieuwenhuis et al, 2005;
Glascher et al, 2010), with some evidence that reward
processing in this region is dopaminergically mediated
(Medic et al, 2014); in this regard it is of interest that
dysfunction of this region was specific to schizophrenia.
Parietal activation associated with the uncertainty of
outcomes has previously been shown to be abnormal in
schizophrenia (Paulus et al, 2003). In the medial prefrontal
cortex, including the superior frontal gyrus and
anterior paracingulate, activation in both patient groups
was significantly abnormal (showing hypoactivation to
unexpected reward receipt) with the schizophrenia group
showing significantly greater abnormality than the depres-
sion group. Medial frontal and anterior cingulate hypoacti-
vation has been reported during the receipt of an expected
reward in schizophrenia (Schlagenhauf et al, 2009;
Waltz et al, 2010), and preclinical studies indicate that these
cortical regions are critical for motivated behavior (Walton
et al, 2002, 2003; Rudebeck et al, 2006).
Relationship Between Brain Responses to an Unexpected
Reward And Motivational Scores
Motivation to play the game was positively associated with
activation to unexpected reward in a cluster situated in
medial prefrontal areas, including the anterior cingulate and
paracingulate gyrus, in the whole sample (adjusting for
diagnosis); this cluster overlapped with the medial prefrontal
cluster in which schizophrenia participants showed lower
activation than controls and depression, and depression
participants showed lower activation than controls, when
receiving an unexpected reward. This evidence of an
association between brain response to unexpected reward
receipt and motivation, rather than pleasure, adds complex-
ity and nuance to models of reward processing that parse
pleasure and motivation into separable psychological
processes with distinct neural components. However, a
full-model should take account of how unexpected reward-
related responses influences future behavior through
motivation. Although SHAPS scores were associated
with task-related measures of motivation, and brain activa-
tion in the medial prefrontal cortex was associated with task-
related motivation, there was no direct association between
brain activation and SHAPS scores, suggesting that medial
prefrontal activation may be indirectly associated with
anhedonic symptoms via its association with task-related
motivation. Our results suggest that medial prefrontal and
anterior cingulate activation to unexpected reward receipt
may be a mechanism that enables the brain to update the
motivational state to reinforce actions that maximize future
reward.
Our finding, linking neural response to a reward receipt
with an index of motivation, is reminiscent of the results of
Waltz et al (2009) who found that putamen and gustatory
cortex responses to sweet liquid rewards predicted clinical
avolition as measured by the SANS. Our findings extend
those of Waltz et al (2009) to relationships between reward
receipt and motivation to the medial prefrontal and anterior
cingulate cortices, key regions in processing reward informa-
tion and in goal-directed behavior (Knutson et al, 2001, 2003;
Volz et al, 2005; Kringelbach and Berridge, 2009; Haber and
Knutson, 2010), which are implicated in the pathophysiology
of both depression and schizophrenia (Fornito et al, 2008;
Drevets, 2001).
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Figure 4 The upper panel shows the mean percent signal change for
unexpected reward receipt for the left ventral striatal/orbitofrontal cluster
where both patient groups had suppressed activation relative to controls. In
contrast, the lower panel shows the mean percent signal change for
unexpected reward receipt in the left lateral parietal lobe (angular gyrus and
supramarginal gyrus) where activation was suppressed in schizophrenia
compared with controls but relatively intact in depression. Error bars are
95% confidence intervals. For graphs of results of other clusters please see
Supplementary Material.
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Taken together our results indicate an important role for
the medial prefrontal cortex and anterior cingulate in the
genesis of anhedonic symptoms (especially in schizophre-
nia). We show that the activity in these regions is reduced in
schizophrenia compared with controls during unexpected
reward receipt, that the degree of reward receipt related
activation in this area is associated with the degree of
motivation to continue playing a game, and that the degree
of motivation to continue playing in our experiment relates
to severity of anhedonia in schizophrenia.
Limitations
One significant limitation of the current study is that all the
schizophrenia patients and about half the depression patients
were taking psychotropic medication, given that both of
these classes of medication have been shown to affect brain
activity during reward processing experiments. In experi-
ments in healthy volunteers, certain antipsychotics and
antidepressants have been shown to result in reduced
reward-related brain activation (Pessiglione et al, 2006;
Abler et al, 2007; Graf et al, 2014; Macovaneau, 2014); other
experiments in healthy controls and in patients with
schizophrenia have suggested that atypical antipsychotic
medications may improve reward-related brain activation
relative to placebo (Jocham et al, 2011) or to typical
antipsychotic medication (Kirsch et al, 2007). The balance
of the (limited) evidence suggests that antidepressant and
(atypical) antipsychotic treatment help normalize brain
responses to reward-related stimuli in patients with depres-
sion (Stoy et al, 2012) and schizophrenia (Nielsen et al,
2012), respectively. All of our schizophrenia participants
were taking atypical antipsychotic medication. Given that we
did not find significant differences between medicated vs
unmedicated depressed participants and no associations
between brain activity and dose of medication, it is not likely
that medication completely explains the reward processing
group differences observed in our study, though we
recognize that studies in patients not taking medication are
required to confirm our results. We note that there have been
some previous studies documenting altered striatal reward
prediction error signaling in unmedicated schizophrenia
patients (eg, Schlagenhauf et al, 2014). All of our patient
participants subjectively endorsed at least some degree of
anhedonia, so our results may not be representative of
patients with schizophrenia and depression who are not
anhedonic. The measure of anhedonia that we used, the
SHAPS, provides a summary measure of anhedonia and does
not distinguish between different components.
The task we used delivered unpredictable rewards, and as
such rewards were surprising (and hence associated with
positive reward prediction error). The activity formed by our
contrast of interest (unexpected reward receipt vs full miss),
could reflect either activity due to reward value or reward
prediction error, hence inferences should be drawn accordingly.
Our findings of some similarities in dysfunction of the
brain representations of unexpected reward receipt in
depression and schizophrenia is broadly consistent with
recent reports that examined a related area of reward
processing—reward anticipation—in patients with a variety
of psychiatric disorders (Hägele et al, 2014; Arrondo et al,
2015). In a fascinating analysis, Hägele et al (2014) pooled a
large number of patients with depression, schizophrenia,
ADHD, mania, and alcohol dependence, who had all
previously taken part in separate case-control studies using
a reward anticipation task, and found evidence of right
ventral striatal dysfunction linked to depressive symptom
severity across diagnostic categories. This finding, and our
results indicating shared areas of reward-related pathophy-
siology across disorders, are highly relevant to the
RDoC initiative, and are supportive of its dimensional
approach to psychopathology. RDoC aims to increase
research that validates new cross-diagnostic dimensions that
will ultimately inform future diagnostic systems (Cuthbert,
2014). One proposed RDoc domain is ‘positive valence
systems’, and proposed dimensions within that domain
include responsiveness to reward, approach motivation,
reward prediction error, and reward learning. Our approach
is in keeping with the RDoc framework, and our results may
encourage further research examining areas of commonality
(and difference) across various dimensions of reward
processing in a cross-diagnostic fashion.
CONCLUSION
In this study we provide evidence of similar hypofunction of
the striatum and orbitofrontal cortex in both schizophrenia
and depression during receipt of an unexpected reward.
Similarities in the way that reward processing was disturbed
in both disorders suggests that there may be at least some
shared pathophysiology common to both disorders, which
may indicate that similar treatments could be effective in
both conditions in some circumstances.
We also show that the degree of frontal activation whilst
playing a computer reward game is linked to subjective
experience of motivation and that measure in turn is associated
with severity of anhedonia (in schizophrenia), suggesting a
possible causal pathway between brain activity, immediate
measures of motivation, and longer-term levels of anhedonia.
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